1/B

The Santa Clara study co-authored by Bendavid, Bhattacharya, Ioannidis, etc. is now out.

Time to once again cover the reasons why it's very wrong.

medrxiv.org/content/10.110…

"COVID-19 antibody seroprevalence in Santa Clara County, California"
academic.oup.com/ije/advance-ar…
2/B

Let's set aside the funding / conflicts of interest underlying the paper, and other such issues. See @stephaniemlee's insightful reporting on that.

This thread will focus more on the scientific points.

buzzfeednews.com/article/stepha…

buzzfeednews.com/article/stepha…
3/B

Background:

When a virus infects u, your body increases production of proteins known as antibodies, which are usually specific to that virus.

So measuring antibodies lets u estimate who was infected, and from that the infection fatality rate (IFR).

institutefordiseasemodeling.github.io/nCoV-public/an…
4/B

The study measured how many people had this antibody increase, to estimate the number of people infected with SARS-CoV-2. They then calculated IFR by dividing the number of COVID-19 deaths by the number of infected people.

Sound familiar?

5/B

There are at least two main ways to screw up on IFR:

1) get the number of COVID-19 deaths wrong
2) get the number of SARS-CoV-2 infections wrong

The Santa Clara study messes up most badly on point 2.



academic.oup.com/ije/advance-ar…
6/B

Instead of selecting people at random and focusing on them for testing, they instead use non-randomly-selected volunteers.

That results in a non-representative sample that over-estimates the number of infections.



academic.oup.com/ije/advance-ar…
7/B

They did not have to do it this way.


For example, there's another study in Santa Clara that uses randomized sampling (CA-FACTS):
med.stanford.edu/epidemiology-d…
ca-facts.org



link.springer.com/article/10.100…
8/B

They try to adjust (or weight) their sample to make it more representative of the general population in Santa Clara.

That might work if they had randomly selected people. But as we just saw, their sample is non-random.



academic.oup.com/jid/article/22…
9/B

If @stephaniemlee is correct and misleading information was used to recruit *some* members of the sample, then that should make us even less sure than the sample is randomized.

That is a non-random, unevenly-distributed means of recruiting people.

buzzfeednews.com/article/stepha…
10/B

So the Santa Clara study over-estimated the number of infected people by using non-random sampling.

But it also likely did so via the antibody test it uses. @stephaniemlee's shows these complaints from those checking the accuracy of the test:

buzzfeednews.com/article/stepha…
11/B

The authors state:
"The raw prevalence of antibodies in our sample was 1.5% [...]. [...] unweighted prevalence adjusted for test-performance characteristics was 1.2% [...]"
academic.oup.com/ije/advance-ar…

Others get lower values:

bfi.uchicago.edu/working-paper/…

medrxiv.org/content/10.110…
12/B

Another problem is the authors over-estimating how certain they can be about the accuracy of their antibody test.

medrxiv.org/content/10.110…

Uncertainty may be so large that their results cannot statistically rule out *almost no one being infected.*

rss.onlinelibrary.wiley.com/doi/epdf/10.11…
13/B

They defend their case by saying a study on dialysis patients yielded an IFR similar to their's:
academic.oup.com/ije/advance-ar…

That's damning, since dialysis studies over-estimate the number of infections:




link.springer.com/article/10.100…
14/B

They defend their results by citing a Los Angeles study (also co-authored by Bendavid + Bhattacharya).

When Ioannidis inferred IFR from that study, it required more people be infected that actually exist.
So it's impossible.


15/B

There are other problems, but I'll stop here, at least for awhile. It should be clear the study is unreliable.

Interestingly, applying its 0.17% IFR now entails >51% of Santa Clara is infected
coronavirus.jhu.edu/us-map

There goes early herd immunity
17/B

Many people are responding by asking how this paper was published.

Context on that below:


18/B

I've been critical of the Santa Clara study, but its IFR estimate of 0.17% represents a substantial improvement over the ~0.01% estimate Bendavid + Bhattacharya gave in late March

~0.01% requires the US population be >14X larger than it actually is

archive.is/QLmJt#selectio…
19/B

I'd put Santa Clara's IFR between ~0.4% - ~1.0%

@youyanggu's model over-estimates the number of infections
archive.is/eYgGL#selectio…

But even it gives an April IFR of ~0.4% (w/ a 2 week lag for deaths)
web.archive.org/web/2021022318…
coronavirus.jhu.edu/us-map

medrxiv.org/content/10.110…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Atomsk's Sanakan

Atomsk's Sanakan Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @AtomsksSanakan

24 Feb
1/E

Various southeast Asian nations suffered relatively few COVID-19 deaths per capita, especially in comparison to many "western" nations.

There's been a lot of speculation on why this is.
So this thread will examine some possible explanations.

archive.is/FkAho Image
2/E

There are at least 3 types of explanation for what's occurring in various southeast Asian countries:

1) insufficient testing that misses many infections and/or misses many COVID-19 deaths
2) lower number of infections
3) lower proportion of infected people die of COVID-19
3/E

For explanation 1:
It's unlikely their testing misses more deaths, since their excess deaths don't outpace their reported COVID-19 deaths more than in many 'western' countries.

nytimes.com/interactive/20…
bbc.com/news/world-530…
economist.com/graphic-detail…

ncbi.nlm.nih.gov/pmc/articles/P… ImageImageImageImage
Read 13 tweets
19 Feb
1/M

Many contrarians cite the Wall Street Journal (WSJ) article below from @MartyMakary.

A good rule-of-thumb is to not rely on what WSJ says about science, especially science they find inconvenient for their right-wing ideology.

I'll illustrate why.

wsj.com/articles/well-…
2/M

Some background:
- PFR, or population fatality rate, is COVID-19 deaths per capita (i.e. per the total population)
- IFR, or infection fatality rate, is COVID-19 deaths per infected person

Makary gives an IFR of 0.23% for the USA:

archive.is/vsDyt#selectio…
3/M

Mackary likely uses John Ioannidis' long-debunked paper:
who.int/bulletin/volum…

That makes no sense since 0.23% is Ioannidis' *global* estimate. The USA's IFR would be higher than that, since IFR increases with age and the USA is older on average

link.springer.com/article/10.100…
Read 16 tweets
16 Feb
1/Y

Ivor Cummins (@FatEmperor) lists articles he claims shows lockdowns are not effective. The Great Barrington Declaration exploited this list.

This thread will debunk Cummins' claim, while giving some further context.

thefatemperor.com/published-pape…

3/Y

Cummins responded to @dr_barrett's thread with a video that is... ridiculous:


There's a comment thread rebutting Cummin's response video:


I'll summarize some of the thread's points here.

Read 27 tweets
6 Feb
1/K

A list of those who so under-estimated the fatality rate of COVID-19, that they *require more people be infected than actually exist.*

(it's amazing there are enough people to include in a list like this 🤷‍♂️)

Sunetra Gupta

coronavirus.data.gov.uk/details/deaths…

2/K

Re: "A list of those who so under-estimated the fatality rate of COVID-19, that they *require more people be infected than actually exist.*"

Nic Lewis

~0.12% of Sweden has now died of COVID-19:
ourworldindata.org/coronavirus-da…
covid19.who.int

judithcurry.com/2020/06/28/the…
3/K

Re: "A list of those who so under-estimated the fatality rate of COVID-19, that they *require more people be infected than actually exist.*"

Michael Levitt

archive.is/3IpJF

Read 12 tweets
5 Feb
1/J

Wanted to address some issues in the thread below from another immunologist.

Should be a nice change-of-pace from dealing with obvious nonsense from disingenuous denialists.



2/J

Serology isn't missing many asymptomatic + pauci-symptomatic infections, once one adjusts for sensitivity based on calibration (long-term sensitivity is better for anti-spike vs. anti-nucleocapsid)



jvi.asm.org/content/95/3/e…

immunology.sciencemag.org/content/5/54/e…
3/J

You're not going to get places with >55% seroprevalence with high specificity tests, if you're missing a lot of infections.



66% - 70%: medrxiv.org/content/10.110…
74%: icddrb.org/news-and-event…

academic.oup.com/ofid/advance-a…

ins.gov.co/BibliotecaDigi…
Read 9 tweets
3 Feb
1/B

Some sources on this for those curious about how long antibodies against SARS-CoV-2 persist after infection.

I'll focus on longitudinal studies that test and re-test the same infected people.

2/B

Also, I'll focus on studies that did representative sampling of the general population.
So no sampling just hospital patients, blood donors, healthcare workers, etc.

St. Petersburg, Russia:

medrxiv.org/content/10.110…



eusp.org/en/news/over-1… Image
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!